A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma. Pal, S. K., Mortazavi, A., Milowsky, M. I., Vaishampayan, U. N., Parikh, M., Lyou, Y., Wang, P., Parikh, R., Teply, B. A., Dreicer, R., Emamekhoo, H., Michaelson, M., Hoimes, C. J., Zhang, T., Srinivas, S., Kim, W. Y., Liu, G., Frankel, P., Cui, Y., Lara, P. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.4507

View details for Web of Science ID 000708120602255